-
ALK+NSCLC: Just one step away from "live longer" to "have to live better
Time of Update: 2022-08-20
*For medical professional reading reference onlyBrigatinib officially entered clinical application in China, helping clinical patients to fully benefit Tumor-targeted therapy has changed the clinical practice of lung cancer, making anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC) move toward "precision" and "long survival" .
-
What about EGFR-TKI resistance
Time of Update: 2022-01-24
After gefitinib treatment, the tumor progressed to stage IV and developed secondary resistance to EGFR, and the gene test was EGFR 19del with MET amplification .
-
Anqing Petrochemical launches green and low-carbon procurement
Time of Update: 2021-09-13
Sinopec News Network News In order to deeply implement the green and clean development strategy and implement the high-quality green enterprise action plan, Anqing Petrochemical fully taps new momentum for material supply, continuously improves the green procurement strategy management mechanism, and incorporates safety and environmental protection management into the supplier access inspection content , Incorporate energy conservation and environmental protection indicators, low-carbon performance, etc.
-
Blood pressure management strategies for ischemic stroke: from the acute phase to secondary prevention
Time of Update: 2021-08-06
Guidelines Recommendation: 2019 AHA/ASA Guidelines for Early Management of Acute Ischemic Stroke: Patients who have not received intravenous thrombolysis but plan intra-arterial treatment in the new Before the emergence of the evidence, it is reasonable to control the preoperative blood pressure to be ≤185/110mmHg .
-
Cell publication reveals the secret behind the threat of non-alcoholic liver disease
Time of Update: 2021-07-31
" Loss of identity can lead to dysfunctionResearchers use comparative genomics to analyze the mechanisms that control the development and special functions of the most abundant cell types in the liver.
-
ESMO releases clinical practice guidelines for small cell lung cancer; domestic marketing application for the third-generation ALK inhibitor loratinib has been accepted|Tumor News
Time of Update: 2021-04-23
03CCR: The use of dexrazoxane did not reduce the progression-free survival of patients with soft tissue sarcoma receiving first-line doxorubicin treatment.
-
Guangdong detected 18 batches of unqualified food, involving microbial contamination, agricultural and veterinary drug residues, food additives and other issues
Time of Update: 2021-01-26
Food Partners Network News August 18, Guangdong Provincial Market Supervision Bureau released the 31st issue of 2020 food safety sampling information, Guangdong Provincial Market Supervision Bureau or
-
The clinical detailed results of the new antibiotic combination of Mercadon to treat bacterial pneumonia in stage 3 were published
Time of Update: 2020-05-30
On May 6th, U.S time, Mercado released detailed results for a Phase 3 clinical trial (RESTORE-IMI 2) evaluating the efficacy and safety of adult patients with hospital acquired/ventilator-related bact
-
How long can the strength of domestic soybeans last
Time of Update: 2003-03-13
Introduction: after the Spring Festival, domestic soybean prices not only didn't fall as expected, but also rose slightly, which made many market analysts fall sharply With the soybean harvest in Sout
-
Korea kocopia will buy 105000 tons of non GMO corn
Time of Update: 2001-03-15
; [Korea kocopia will buy 105000 tons of non GMO corn] Kocopia, the only edible corn purchasing group in South Korea, will hold a bidding on Thursday afternoon to purchase 105000 tons of corn from any
